참고문헌
- Conscious Sedation TFT Committee of KSGE. A guidebook on sedation for gastrointestinal endoscopy. Seoul: Medbook; 2015.
- Training Committee. American Society for Gastrointestinal Endoscopy. Training guideline for use of propofol in gastrointestinal endoscopy. Gastrointest Endosc 2004;60:167-172.
- Waring JP, Baron TH, Hirota WK, et al. Guidelines for conscious sedation and monitoring during gastrointestinal endoscopy. Gastrointest Endosc 2003;58:317-322.
- Goudra BG, Singh PM. Propofol alternatives in gastrointestinal endoscopy anesthesia. Saudi J Anaesth 2014;8:540-545.
- Goudra B, Gouda G, Mohinder P. Recent developments in drugs for GI endoscopy sedation. Dig Dis Sci 2020;65:2781-2788.
- Forman SA. Clinical and molecular pharmacology of etomidate. Anesthesiology 2011;114:695-707.
- Han SJ, Lee TH, Yang JK, et al. Etomidate sedation for advanced endoscopic procedures. Dig Dis Sci 2019;64:144-151.
- Lee JM, Min G, Lee JM, et al. Efficacy and safety of etomidate-midazolam for screening colonoscopy in the elderly: a prospective double-blinded randomized controlled study. Medicine (Baltimore) 2018;97:e10635.
- Zhou X, Li BX, Chen LM, et al. Etomidate plus propofol versus propofol alone for sedation during gastroscopy: a randomized prospective clinical trial. Surg Endosc 2016;30:5108-5116.
- Chen L, Liang X, Tan X, et al. Safety and efficacy of combined use of propofol and etomidate for sedation during gastroscopy: systematic review and meta-analysis. Medicine (Baltimore) 2019;98:e15712.
- Kim JH, Byun S, Choi YJ, et al. Efficacy and safety of etomidate in comparison with propofol or midazolam as sedative for upper gastrointestinal endoscopy. Clin Endosc 2020;53:555-561.
- Scheinin H, Aantaa R, Anttila M, et al. Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific alpha2-adrenoceptor antagonist atipamezole: a pharmacodynamic and kinetic study in healthy volunteers. Anesthesiology 1998;89:574-584.
- Liu W, Yu W, Yu H, et al. Comparison of clinical efficacy and safety between dexmedetomidine and propofol among patients undergoing gastrointestinal endoscopy: a meta-analysis. J Int Med Res 2021;49:3000605211032786.
- Chen YT, Sun CK, Wu KY, et al. The use of propofol versus dexmedetomidine for patients receiving drug-induced sleep endoscopy: a meta-analysis of randomized controlled trials. J Clin Med 2021;10:1585.
- Nishizawa T, Suzuki H, Hosoe N, et al. Dexmedetomidine vs propofol for gastrointestinal endoscopy: a meta-analysis. United European Gastroenterol J 2017;5:1037-1045.
- Nishizawa T, Suzuki H, Sagara S, et al. Dexmedetomidine versus midazolam for gastrointestinal endoscopy: a meta-analysis. Dig Endosc 2015;27:8-15.
- Belleville JP, Ward DS, Bloor BC, et al. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology 1992;77:1125-1133.
- Hall JE, Uhrich TD, Barney JA, et al. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 2000;90:699-705.
- Jalowiecki P, Rudner R, Gonciarz M, et al. Sole use of dexmedetomidine has limited utility for conscious sedation during outpatient colonoscopy. Anesthesiology 2005;103:269-273.
- Zhang F, Sun HR, Zheng ZB, et al. Dexmedetomidine versus midazolam for sedation during endoscopy: a meta-analysis. Exp Ther Med 2016;11:2519-2524.
- Kilpatrick GJ, McIntyre MS, Cox RF, et al. CNS 7056: a novel ultra-short-acting benzodiazepine. Anesthesiology 2007;107:60-66.
- Goudra BG, Singh PM. Remimazolam: the future of its sedative potential. Saudi J Anaesth 2014;8:388-991.
- Borkett KM, Riff DS, Schwartz HI, et al. A phase IIa, randomized, double-blind study of remimazolam (CNS 7056) versus midazolam for sedation in upper gastrointestinal endoscopy. Anesth Analg 2015;120:771-780.
- Chen SH, Yuan TM, Zhang J, et al. Remimazolam tosilate in upper gastrointestinal endoscopy: a multicenter, randomized, non-inferiority, phase III trial. J Gastroenterol Hepatol 2021;36:474-481.
- Zhu X, Wang H, Yuan S, et al. Efficacy and safety of remimazolam in endoscopic sedation-a systematic review and meta-analysis. Front Med (Lausanne) 2021;8:655042.
- Jhuang BJ, Yeh BH, Huang YT, et al. Efficacy and safety of remimazolam for procedural sedation: a meta-analysis of randomized controlled trials with trial sequential analysis. Front Med (Lausanne) 2021;8:641866.
- Domino EF, Chodoff P, Corssen G. Pharmacologic effects of CI581, a new dissociative anesthetic, in man. Clin Pharmacol Ther 1965;6:279-291.
- Cohen LB, Delegge MH, Aisenberg J, et al. AGA institute review of endoscopic sedation. Gastroenterology 2007;133:675-701.
- Akbulut UE, Saylan S, Sengu B, et al. A comparison of sedation with midazolam-ketamine versus propofol-fentanyl during endoscopy in children: a randomized trial. Eur J Gastroenterol Hepatol 2017;29:112-118.
- Eskander AE, Baroudy NR, Refay AS. Ketamine sedation in gastrointestinal endoscopy in children. Open Access Maced J Med Sci 2016;4:392-396.
- Lee YM, Kang B, Kim YB, et al. Procedural sedation for pediatric upper gastrointestinal endoscopy in Korea. J Korean Med Sci 2021;36:e136.
- Fechner J, Ihmsen H, Jeleazcov C, et al. Fospropofol disodium, a water-soluble prodrug of the intravenous anesthetic propofol (2,6-diisopropylphenol). Expert Opin Investig Drugs 2009;18:1565-1571.
- Cohen LB. Clinical trial: a dose-response study of fospropofol disodium for moderate sedation during colonoscopy. Aliment Pharmacol Ther 2008;27:597-608.
- Toklu S, Iyilikci L, Gonen C, et al. Comparison of etomidate-remifentanil and propofol-remifentanil sedation in patients scheduled for colonoscopy. Eur J Anaesthesiol 2009;26:370-376.
- Mandel JE, Tanner JW, Lichtenstein GR, et al. A randomized, controlled, double-blind trial of patient-controlled sedation with propofol/remifentanil versus midazolam/fentanyl for colonoscopy. Anesth Analg 2008;106:434-439.
- Fossler MJ, Sadler BM, Farrell C, et al. Oliceridine (TRV130), a novel G protein-biased ligand at the μ-opioid receptor, demonstrates a predictable relationship between plasma concentrations and pain relief. I: development of a pharmacokinetic/pharmacodynamic model. J Clin Pharmacol 2018;58:750-761.
- Food and Drug Administration (FDA). FDA approved drug products: Olinvyk (Oliceridine) injection [Internet]. Silver Spring (MD): FDA; 2020 [cited 2022 Jan 17]. Available from: https://www.access-data.fda.gov/drugsatfda_docs/label/2020/210730s000lbl.pdf.
- Singla N, Minkowitz HS, Soergel DG, et al. A randomized, phase IIb study investigating oliceridine (TRV130), a novel μ-receptor G-protein pathway selective (μ-GPS) modulator, for the management of moderate to severe acute pain following abdominoplasty. J Pain Res 2017;10:2413-2424.
- Liang DY, Li WW, Nwaneshiudu C, et al. Pharmacological characters of oliceridine, a μ-opioid receptor G-protein-biased ligand in mice. Anesth Analg 2019;129:1414-1421.